BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26038208)

  • 1. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line.
    Stelcer E; Milecka P; Komarowska H; Jopek K; Tyczewska M; Szyszka M; Lesniczak M; Suchorska W; Bekova K; Szczepaniak B; Ruchala M; Karczewski M; Wierzbicki T; Szaflarski W; Malendowicz LK; Rucinski M
    Front Endocrinol (Lausanne); 2020; 11():561370. PubMed ID: 33133015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity.
    Ishikawa Y; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Tokodai K; Fujishima F; Kawanabe S; Katabami T; Ikeya A; Yamashita M; Oki Y; Nanjo H; Satoh F; Ito A; Unno M; Kamei T; Sasano H; Suzuki T
    J Steroid Biochem Mol Biol; 2024 Apr; 238():106462. PubMed ID: 38232786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen.
    Wang L; Lyu Y; Li Y; Li K; Wen H; Feng C; Li N
    Aging (Albany NY); 2021 Sep; 13(18):22286-22297. PubMed ID: 34536950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: A rare combination of aldosterone-secreting adrenocortical carcinoma and papillary thyroid carcinoma with Graves' disease.
    Zhang Y; Yu J; Fan C; Wang F; Liu H; Chen K
    Front Endocrinol (Lausanne); 2024; 15():1310408. PubMed ID: 38645425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma.
    Chortis V; Taylor AE; Doig CL; Walsh MD; Meimaridou E; Jenkinson C; Rodriguez-Blanco G; Ronchi CL; Jafri A; Metherell LA; Hebenstreit D; Dunn WB; Arlt W; Foster PA
    Endocrinology; 2018 Aug; 159(8):2836-2849. PubMed ID: 29850793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma.
    Lalli E
    Front Endocrinol (Lausanne); 2023; 14():1303332. PubMed ID: 38155952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSCN1 as a new druggable target in adrenocortical carcinoma.
    Ruggiero C; Tamburello M; Rossini E; Zini S; Durand N; Cantini G; Cioppi F; Hantel C; Kiseljak-Vassiliades K; Wierman ME; Landwehr LS; Weigand I; Kurlbaum M; Zizioli D; Turtoi A; Yang S; Berruti A; Luconi M; Sigala S; Lalli E
    Int J Cancer; 2023 Jul; 153(1):210-223. PubMed ID: 36971100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer.
    Mohan DR; Borges KS; Finco I; LaPensee CR; Rege J; Solon AL; Little DW; Else T; Almeida MQ; Dang D; Haggerty-Skeans J; Apfelbaum AA; Vinco M; Wakamatsu A; Mariani BMP; Amorim LC; Latronico AC; Mendonca BB; Zerbini MCN; Lawlor ER; Ohi R; Auchus RJ; Rainey WE; Marie SKN; Giordano TJ; Venneti S; Fragoso MCBV; Breault DT; Lerario AM; Hammer GD
    Cancer Res; 2023 Jul; 83(13):2123-2141. PubMed ID: 37129912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma.
    Kitamura T; Blinder AR; Nanba K; Tsuiki M; Mishina M; Okuno H; Moriyoshi K; Yamazaki Y; Sasano H; Yoneyama K; Udager AM; Rainey WE; Yasoda A; Satoh-Asahara N; Tagami T
    Eur J Endocrinol; 2022 Dec; 187(6):K39-K45. PubMed ID: 36691941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted genomic analysis of 364 adrenocortical carcinomas.
    Pozdeyev N; Fishbein L; Gay LM; Sokol ES; Hartmaier R; Ross JS; Darabi S; Demeure MJ; Kar A; Foust LJ; Koc K; Bowles DW; Leong S; Wierman ME; Kiseljak-Vassiliades K
    Endocr Relat Cancer; 2021 Aug; 28(10):671-681. PubMed ID: 34410225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of the 5th edition WHO classification of adrenal cortical tumors].
    Zhang LK; Liu ZY
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):16-21. PubMed ID: 38178741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Expression of Humanin during Adrenocortical Carcinoma.
    Blatkiewicz M; Szyszka M; Olechnowicz A; Kamiński K; Jopek K; Komarowska H; Tyczewska M; Klimont A; Wierzbicki T; Karczewski M; Ruchała M; Rucinski M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma.
    Pak C; Yoon S; Lee JL; Yun T; Park I
    Curr Oncol Rep; 2024 Apr; 26(4):307-317. PubMed ID: 38381366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of hiPSC-derived cells differentiated with growth factors, forskolin and conditioned medium from human adrenocortical cell line.
    Stelcer E; Jopek K; Blatkiewicz M; Olechnowicz A; Kamiński K; Szyszka M; Suchorska WM; Ruciński M
    Adv Clin Exp Med; 2024 Apr; 33(4):397-407. PubMed ID: 37540158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Damage-Net: A program for DNA repair meta-analysis identifies a network of novel repair genes that facilitate cancer evolution.
    Bader AS; Bushell M
    DNA Repair (Amst); 2021 Sep; 105():103158. PubMed ID: 34147942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular landscape of adrenocortical carcinoma at single-nuclei resolution.
    Tourigny DS; Altieri B; Secener KA; Sbiera S; Schauer MP; Arampatzi P; Herterich S; Sauer S; Fassnacht M; Ronchi CL
    Mol Cell Endocrinol; 2024 May; 590():112272. PubMed ID: 38759836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of estrogen-secreting adrenocortical carcinoma: Comprehensive immunohistochemical analysis of disorganized steroid genesis.
    Yokoyama M; Kijima T; Takada-Owada A; Sakamoto K; Suzuki I; Nishihara D; Nakamura Y; Ishida K; Kamai T
    IJU Case Rep; 2021 Sep; 4(5):318-321. PubMed ID: 34497994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.
    Mizdrak M; Tičinović Kurir T; Božić J
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33578890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.